MEDIBIOFARMA announced the first patient dosed in the Phase IIa clinical trial of MBF-118 in patients with Crohn’s disease.
Navarra – May 10, 2023 – Medibiofarma S.L., a clinical-stage biotechnology company developing aportfolio of new therapies for the treatment of gastrointestinal (GI) diseases as well as othercancer and...